Canntab Therapeutics Ltd (PILL) Company Profile

Canntab Therapeutics Ltd Company Snapshot

Canntab Therapeutics Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Canntab Therapeutics Ltd with three other companies in this sector in CANADA : Choom Holdings Inc (2019 sales of 268,321.00 Canadian Dollars [US$203,119.00 ] ), FSD Pharma Inc (257,099.00 Canadian Dollars [US$194,623.94 ] of which 100% was Medical purpose regulation), and Benchmark Botanics Inc (235,777.00 Canadian Dollars [US$178,483.19 ] ).

Sales Analysis.

Canntab Therapeutics Ltd

Stock Data:

Recent Stock Performance:

Current Price (9/17/2020): .65
(Figures in Canadian Dollars)

1 Week	1.6%	13 Weeks	-4.4%

4 Weeks	-32.3%	52 Weeks	8.3%

Canntab Therapeutics Ltd Key Data:

Ticker:	PILL	Country:	Canada

Exchanges:	MON	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Medicinals & Botanicals

2019 Sales	239,999 (Year Ending Jan 2020).	Employees:	10

Currency:	Canadian Dollars	Market Cap:	21,292,441

Fiscal Yr Ends:	May	Shares Outstanding:	32,757,601

Share Type:	Common	Closely Held Shares:	8,190,500

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.